Status:
NOT_YET_RECRUITING
Breisgau Pheno Heart Study
Lead Sponsor:
University Hospital Freiburg
Conditions:
Myocardial Infarction
STEMI
Eligibility:
All Genders
18-85 years
Brief Summary
Coronary heart disease and its acute complication, myocardial infarction (MI), represent the leading causes of death in Europe and the United States. Although novel treatment strategies have helped to...
Eligibility Criteria
Inclusion
- Emergency coronary angiography and age\>18 years and STEMI or NSTEMI or "none of these diseases"
Exclusion
- Hemoglobin\<7,0 g/dl
- Platelets \<50.000/µl
- Unable to provide written informed consent
- Age \> 80 years
- hematological neoplasia
- metastasized cancers
- acute infection (z.B. Sepsis)
- Chronic Inflammatory conditions (z.B. inflammatory bowel disease, Rheumatoid arthritis, chronisch hepatitis)
- Pregnancy
- Immunosuppression
- Resuscitation \>5 min oder mehr als 1x Defibrillation vor Koronarangiographie
- Cardiogenic shock
- Mechanical circulatory support
- Cardiomyopathy with an left ventricular ejection fraction F \<40% before the event
- Dialysis
- Cirrhosis \> CHILD-A
- Not living in the county of Breisgau-Hochschwarzwald or Emmendingen oder planned relocation
- Alcohol and drug abuse
- Non-compliance
Key Trial Info
Start Date :
April 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2034
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06166407
Start Date
April 1 2024
End Date
April 1 2034
Last Update
December 19 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.